Drug Pipeline
| Title | Published | Pages | Region | Price | |
|---|---|---|---|---|---|
| Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis | Aug 1 2017 | 113 | Global | $6,995.00 | |
| Hepatitis Drug Development Pipeline Review, 2017 | Aug 1 2017 | 209 | Global | $3,995.00 | |
| Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017 | Aug 1 2017 | 254 | Global | $3,995.00 | |
| Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017 | Aug 1 2017 | 138 | Global | $3,995.00 |